Peptides/Peptidic Foldamers

Chris Coxon is a medicinal chemist and chemical biologist at the University of Edinburgh. His research interests are in peptide design, synthesis and the effects and applications of fluorination to control and study peptide and protein folding, recognition and assembly.

Lorna is a Professor of Chemistry whose research centres around understanding protein folding and misfolding using a combination of experimental and theoretical approaches. In the area of Foldamers her work is particularly concentrated on MD simulations of peptides containing non-proteinogenic amino acids.

Nick's group focuses on the development of new bioconjugation methodologies. Current projects include the exploration of photocatalytic, biocatalytic, and electrochemical methods for the site-selective modification of peptides and proteins.

Jonathan leads a synthetic chemistry group with expertise in design/applications of amide and urea-based with controlled but dynamic conformational properties.

Manuel is the head of a lab that focuses on developing and applying chemical biology tools to elucidate how proteins are controlled by post-translational modifications.

Steven is the Director of the Biophysical Sciences institute and his research group uses a range of methods and techniques in synthetic organic, peptoid and peptide chemistry to tackle interesting and challenging biological problems.

Sarah is the lead of a synthetic supramolecular group based in the School of Chemistry at the University of Birmingham. Their research focuses on the development of new responsive supramolecular systems.

Scott is the lead investigator of a group which spans organic, physical, and bioorganic chemistry. We combine molecules of synthetic and biological origins to examine the physical organic chemistry underpinning molecular interactions and the operation of molecular machines.

André is the Director of FoldNetUK and lead investigator of a research group focused on the synthesis and application of new peptidic structures, particularly through the development of new methodologies towards unnatural amino acids.